Protalix BioTherapeutics, Inc.

PLX·NYSE American·Healthcare
Compare
2.6900+0.0800 (+3.07%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2.6100
Open2.6100
Day range2.63002.7300
52-week range1.65003.1900
Off day high−1.47%
Off 52-week high−15.67%
Volume870.63K
Avg. volume (3M)774.05K
Market cap216.74M
EPS (TTM)0.2300
Forward P/E4.34
P/E ratio (TTM)11.70
Dividend yield—
Beta (5Y)-0.02
Shares outstanding80.57M
Short interest4.53% of float
Earnings dateNov 10, 2026
Analyst target11.0000
Profit margin23.50%

Against its peers

Compare in full ›
PLX PRTA RGNX VRXA GENO.ST PRQR
Market cap 216.74M 430.72M 508.96M 134.34M 1.47B 198.98M
P/E (TTM) 11.7 — — — 72.8 —
Forward P/E 4.3 -6.4 -2.6 — 46.5 -3.0
Price/book 3.0 1.5 5.8 -0.7 4.8 2.2
Dividend yield — — — — — —
1-year change +9.66% −20.06% −34.28% −90.59% +0.24% −42.44%
Today +3.07% +2.19% +1.05% −4.04% +3.31% +2.92%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All PLX news ›

From the 4Search news index, newest first.

In the news

6mentions in 30 days
2with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance